SCHEMBL23971024

SCHEMBL23971024

COC(=O)c1cc(N)c(N[C@@H]2C[C@@H]2F)cc1F

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.38
ALDH1A1 P00352 7/20 0.38
GAA P10253 6/20 0.37
HSD17B10 Q99714 4/20 0.37
MAPT P10636 3/20 0.37
HPGD P15428 3/20 0.37
GLA P06280 2/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
ATM Q13315 1/20 0.37
CFTR P13569 4/20 0.37
ABL1 P00519 1/20 0.36
TSHR P16473 2/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
ROCK2 O75116 1/20 0.35
ILK Q13418 1/20 0.33
YAP1 P46937 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23971180 1.00 KDM4E (0.38) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL23971182 1.00 KDM4E (0.38) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL23970933 0.87 ALDH1A1 (0.38) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL30850093 0.83 ROCK2 (0.51) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL23970709 0.83 ROCK2 (0.51) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL2248317 0.78 KDM4E (0.46) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL17010488 0.77 ALDH1A1 (0.37) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL17010485 0.77 ALDH1A1 (0.37) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL17010487 0.77 ALDH1A1 (0.37) KDM4EALDH1A1GAAHSD17B10MAPT
SCHEMBL1509484 0.76 KDM4E (0.52) KDM4EALDH1A1GAAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 KDM4E 936/4885ALDH1A1 2537/4885GAA 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.